Navigation Links
Nile Therapeutics CD-NP Clinical Program for Acute Heart Failure Released From Clinical Hold by FDA
Date:5/15/2009

SAN FRANCISCO, May 15 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for heart failure patients, received notification from the U.S. Food and Drug Administration (FDA) that the agency has released the Company's CD-NP development program from clinical hold.

As the next step, the Company will submit to the FDA the finalized protocol for the Company's planned 30-patient single-blind, placebo-controlled Phase 2 study designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with acute heart failure and renal insufficiency. The dosing of the study is expected to be completed by the end of 2009.

About CD-NP

CD-NP is a novel chimeric natriuretic peptide in clinical development for the treatment of acute heart failure. CD-NP was designed to reduce symptoms of dyspnea in heart failure patients through both a reduction in intracardiac pressure and an improvement in renal function. The Company believes that the current preclinical and clinical data supports the pharmacological hypothesis at doses that have been safely tolerated by patients, and provides CD-NP with the potential for favorable differentiation from other acute heart failure therapies. In addition to an initial indication for acute heart failure, CD-NP may have utility in other indications, which include preservation of cardiac function subsequent to acute myocardial infarction (AMI), and prevention of renal damage subsequent to cardiac surgery.

About Nile Therapeutics

Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical needs. Nile i
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Childrens Hospital Boston and Massachusetts General Hospital
2. Cell Therapeutics Closes Italian Facility, Reduces Headcount and Expects to Cut $14 Million in Operating Expenses
3. Cell Therapeutics, Inc. (CTI) to Present at 2009 BIO International Convention
4. Orexigen(R) Therapeutics to Present at Upcoming Meetings
5. Prospect Therapeutics, Inc. Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors
6. Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a Modified Dutch Auction Tender Offer
7. PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration
8. Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy
9. Amicus Therapeutics to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 13, 2009
10. Orexigen(R) Therapeutics to Speak at Upcoming Conferences
11. Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Ambassador to Speak at Economi...o, Canada (Vocus) November 25, 2009 -- Ambassador ... ,David Appia, French Ambassador for International... France Agency ,To view a biography of David Appia...ssador Appia is available to meet with press to di...
(Date:11/25/2009)... , MARKHAM, ON, Nov. 25 /PRNewswire/ - Cytochro... PhD to its Board of Directors. Dr. Moldt will rep...e on the Company,s Board. The number of Board memb...e very pleased to welcome Peter Moldt to the board...e and guidance as Cytochroma continues to make pro...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Repo...report is available in its catalogue: ,, Brazi... ,, http://www.reportlinker.com/p0165503/Braz...3.html ,, Brazil Bioethanol Market Analysis an...rt provides detailed analysis and forecasts of the...
(Date:11/24/2009)...s release is available in German . , Whethe...cards: RFID tags (Radio Frequency Identification) ...ife. They make it possible to label objects or goo...ncy. The appropriate scanner can read and process ...be affixed to goods under production conditions of...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10Intelligence inside metal components 2
...initiative will use health information technology ...drug safety efforts across,the U.S., WASHINGTON, ...ion (eHI) announced today the formation of an inno...afety for patients. The eHI,Connecting Communities...,sector effort designed to test new approaches and...
...r 29 Jerusalem Global Ventures today,announced th...d, L.P., a,$200 million fund. The Fund will invest...hat are on a trajectory to IPO within three years ... scheduled for April 2008., Dr. Shlomo Kalish, wh...like the early stage VC investment model, where on...
... controlling the magnetic properties of a commonly...sing power, according to research published recent...strated that they can control the properties in a ...e use of magnetism. , Though this technology is ...bility to control the magnetic properties of MPc c...
Other Biology Technology:eHealth Initiative Foundation Launches Collaborative Research Effort to Improve Drug Safety 2eHealth Initiative Foundation Launches Collaborative Research Effort to Improve Drug Safety 3eHealth Initiative Foundation Launches Collaborative Research Effort to Improve Drug Safety 4eHealth Initiative Foundation Launches Collaborative Research Effort to Improve Drug Safety 5eHealth Initiative Foundation Launches Collaborative Research Effort to Improve Drug Safety 6Jerusalem Global Ventures Announces $200 Million Growth Equity Fund 2Blue dye could hold the key to super processing power 2Blue dye could hold the key to super processing power 3
(Date:11/30/2009)...to monitor the commitments that will be made by de...restation rates, according to research at the Univ...and research groups have failed to make full use o... surface collected each week to monitor tropical f...ainger in the Proceedings of the National Academy...
(Date:11/30/2009)...s Ron Falta and Larry Murdoch have received an $89...dy the safe storage of carbon dioxide in geologica...e. , With carbon dioxide emissions from burning ...lobal warming, geologic storage of the gas is one ...issions using current technology. , "Geologic st...
(Date:11/30/2009)... , The DFG has approved the establishment of ...ary 2010. This decision was made recently by the r...will initially be funded for four years with a tot...d funding for indirect costs will also be provided...nge from modern prostheses to political reforms to...
Breaking Biology News(10 mins):World forest observatory needed to monitor vital role of forests in climate deal 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9Kids With High IQs Live Longer 54106 1Kids With High IQs Live Longer 54106 2Kids With High IQs Live Longer 54106 3More Evidence Healthy Living Brings Long Life 54102 1More Evidence Healthy Living Brings Long Life 54102 2More Evidence Healthy Living Brings Long Life 54102 3The Elephant in the Room 3A Panel on Immigrations Impact on Health Care Reform 54098 1
...ome a major hurdle to calculating how much carbon ...vital information for understanding how the biosph...unt of carbon that can be safely emitted by human ...neously take up and release CO2. The key finding i... consume in tandem with CO2, can be used to quanti...
...ism discovered in the open ocean may force scienti...nd nitrogen cycle through ocean ecosystems. A rese... sciences at the University of California, Santa C...s genetic material, even though researchers have n...r said the newly described organism seems to be an...
...Methodist University (SMU) and The University of T...emical compounds that slow the degeneration of neu...heimer,s, Parkinson,s and amyotrophic lateral scle...the November 2008 edition of Experimental Biology...Biehl and UTD Biology Professor Santosh D,Mello te...
Other Biology News:Corralling the carbon cycle 2Mysterious microbe may play important role in ocean ecology 2Mysterious microbe may play important role in ocean ecology 3Protecting neurons could halt Alzheimer's, Parkinson's diseases 2
...costs of poor quality running into billions of dol...izations are under increasing pressure to reduce e...icroscopic distribution of ingredients is known to...lution, stability, bio-availability and hardness. ...
...s FLAG Immunoprecipitation kit allows a rapid and ...tive FLAG-tagged protein. The immunoprecipitation ... is a highly specific monoclonal antibody covalent...resin allows an efficient binding of FLAG-tagged p...
...CenSC is a chromogenic medium for the detection, i...la (except S. thyphi) and total coliforms from oth...maximum of 24 hours, needs no additional biochemic...performs a higher diagnostic specificity and sensi...
SlideHyb Glass Array Hybridization Buffer #1 from Ambion
Biology Products: